Post by Novartis Science

Name: In cardiovascular, renal and metabolic disease, Novartis is leaning into what comes next. With a r
Uploaded: 2026-06-05T12:00:00.841Z
Channel: Novartis Science
Description: In cardiovascular, renal and metabolic disease, Novartis is leaning into what comes next. With a robust portfolio and focused pipeline, we’re prioritizing transformative programs that turn strong bi

252,830 followers

In cardiovascular, renal and metabolic disease, Novartis is leaning into what comes next. With a robust portfolio and focused pipeline, we’re prioritizing transformative programs that turn strong biological and technological understanding into treatments with durable impact, with the ambition of promoting longer, healthier lives. #drugdevelopment #pharma

Video Content